If you started HRT expecting to feel better and instead feel worse, more anxious, more bloated, more exhausted, you're not broken and your prescription isn't necessarily wrong. This guide explains why women respond so differently to hormone therapy: from progesterone sensitivity and estrogen delivery method to nervous system variability and fluctuating baselines, and what it means to actually track whether your treatment is working.

If you started HRT expecting to feel better and instead feel worse, more anxious, more bloated, more exhausted, you're not broken and your prescription isn't necessarily wrong. This guide explains why women respond so differently to hormone therapy: from progesterone sensitivity and estrogen delivery method to nervous system variability and fluctuating baselines, and what it means to actually track whether your treatment is working.
The stories are everywhere. One woman describes hormone therapy as the most transformative thing she has ever done, better sleep, sharper thinking, stable mood, energy she has not felt in years. Another started the same treatment, followed the same protocol, and felt anxious, bloated, and worse than before.
Both women are telling the truth. Both responses are real. And the explanation is not that one of them got lucky, or that the other is being too sensitive, or that hormone therapy simply does not work for everyone.
The explanation is that hormone response is profoundly individualized. A prescription is a starting point that often needs personalization, and the experience of that personalization varies enormously from one woman to the next.
This piece is for the woman who started HRT and is still waiting to feel better. It is also for the woman who thrived initially and then plateaued. And it is for the woman who is considering HRT and wants to understand, before she starts, why the experience varies so much.
Why the Same Prescription Can Feel So Different
Hormone therapy works by adding estrogen, and usually progesterone, to support a hormonal system that is producing those hormones erratically or in declining amounts. The logic is straightforward. The experience often is not, because hormones are not added into a static system.
Your hormonal environment during perimenopause is not just low. It is variable. Estrogen does not decline steadily during the transition. It swings, sometimes reaching higher than normal peaks before dropping, then rising again. The timing of those swings differs between women and between cycles in the same woman. Understanding what your hormones should actually look like in the first 90 days of HRT is difficult precisely because "normal" is a moving target in perimenopause.
Layered onto this, every woman's nervous system, liver metabolism, gut microbiome, and receptor sensitivity is different. Two women on identical patches with identical doses can have meaningfully different blood levels of estrogen, and meaningfully different symptom responses, because of how their bodies absorb and process what they are given.
This is why personalization, and visibility into how an individual is responding, can make such a difference.
Why Estrogen Itself Doesn't Always Feel Good
For many women, estrogen is the easier half of HRT. At therapeutic doses, estradiol typically improves hot flashes, sleep quality, mood, and cognitive clarity. But "typically" is doing a lot of work in that sentence.
Some women, particularly those who are sensitive to hormonal fluctuation, find that even therapeutic estrogen levels can feel activating, producing anxiety, heart palpitations, or breast tenderness, especially in the early weeks. This is more likely when estrogen is introduced quickly, when baseline levels were very low before treatment, or when the form of estrogen produces less stable blood levels.
This is one of the reasons delivery method matters significantly. Oral estrogen is metabolized through the liver on its first pass, which affects how it is processed and can elevate certain clotting factors and inflammatory markers. Transdermal delivery, patches, gels, and creams, bypasses first-pass liver metabolism, producing more stable blood levels. For women who are anxious, have migraines, or are more cardiovascular sensitive, transdermal estrogen is often preferred.
But even within transdermal options, absorption varies. Patch sites, skin type, body temperature, and where the patch is applied can all influence how much estrogen actually enters the bloodstream. Two women wearing the same patch can end up with different serum levels. This is part of why a prescription on its own is a starting point. This is why knowing whether your HRT dose is actually right cannot be fully answered by the prescription alone, it requires knowing what your levels are actually doing, continuously, not in a single clinic blood draw taken weeks after initiation.
The Progesterone Problem
For many women who feel worse on HRT, progestogens are more often the contributor, and they get less attention in the conversation than estrogen does.
A progestogen, either bioidentical progesterone or a synthetic progestin, is added to HRT to protect the uterine lining in women on estrogen. Without it, unopposed estrogen significantly raises the risk of uterine cancer. So for women with a uterus, a progestogen is not optional, and it does important work.
For most women, progesterone is well tolerated, and the body-identical form, micronized progesterone (Prometrium), tends to be calming and supportive of sleep. This is one of the reasons it is often preferred when sleep and mood are part of the picture. The nuance, and where variability comes in, is that progesterone affects the brain through a neurosteroid called allopregnanolone, which binds to GABA receptors. In most women, that GABA effect is calming. In a smaller group of women, it produces the opposite effect: low mood, anxiety, brain fog, or a feeling of being emotionally muted. In this smaller group, the same effect can produce low mood, anxiety, brain fog, or a sense of being emotionally muted. This response is the exception rather than the rule, but for women who experience it, recognizing the pattern is what matters, alternative formulations or dosing approaches often help, and it is worth bringing into a conversation with your provider..
Synthetic progestins, such as norethindrone or levonorgestrel found in some combined products, have somewhat androgenic properties and can affect mood, skin, libido, and metabolic markers differently from micronized progesterone. Some women feel better on synthetic forms, others on micronized. There is no universal ranking. The most reliable way to identify which suits a particular woman is to observe symptom changes over time on each.
The takeaway is not that progesterone is the part of HRT to worry about, it is the opposite. This is why progesterone isn't one-size-fits-all either. For most women, the progestogen component is doing important protective work and is well tolerated. For the smaller group who do not feel well on a particular form, knowing that variability exists, and that there are alternatives to consider with a provider, is what allows the issue to be addressed rather than endured.
The Timing and Cyclical Use Variable
Not all HRT regimens are continuous. Some protocols use cyclical progesterone, taken only for part of the month, which means women experience a progestogenic phase and a non-progestogenic phase. For women with progesterone sensitivity, the cyclical phase can produce consistent, predictable windows of low mood, anxiety, bloating, and fatigue. Without tracking, these patterns can be attributed to perimenopause itself rather than to the specific phase of the protocol.
Continuous combined regimens, where low-dose progesterone is taken every day alongside estrogen, eliminate the cyclical pattern but do not eliminate sensitivity. Some women find continuous progesterone better tolerated at lower daily doses. Others do better with cyclical higher doses and the defined windows.
The challenge is that without tracking symptoms against your specific hormonal pattern, day by day, across several weeks, it is hard to know whether a difficult week is correlated with the progesterone phase or with something else. Looking at the pattern over time can help surface those correlations, and is the kind of information that is useful to bring into your own understanding of how your body is responding.
Why Some Women Feel Great Initially, Then Don’t
One of the more disorienting experiences in HRT is feeling dramatically better at first and then plateauing or worsening. Online forums are full of women describing a honeymoon period, a few weeks of meaningful relief, followed by a return of symptoms.
Several mechanisms can explain this.
First, estrogen levels during perimenopause continue to fluctuate even while on HRT. The estrogen from a patch or gel adds to whatever your ovaries are still producing, and during perimenopause, that production is variable. On days when your own estrogen is higher, the combination with your HRT dose can push your total higher than the therapeutic target, producing symptoms of estrogen excess, breast tenderness, bloating, mood swings. On days when your own estrogen is low, your HRT dose may not be enough. Hormonal needs can shift as perimenopause progresses, which is why an approach that worked initially may need to be revisited with your provider.
Second, the nervous system adapts to hormonal shifts. Women who have been in a low estrogen state for months or years may find that a relatively rapid increase in estrogen, even to a therapeutic level, feels activating at first, before the nervous system has a chance to recalibrate. This does not mean HRT is wrong for them. It often means the body needs time to adjust.
Third, sleep is often a lagging indicator. Many women experience improvements in hot flashes and daytime mood before their sleep architecture fully recovers. When daytime symptoms ease quickly but sleep is still disrupted, fatigue can compound over time, which can feel like HRT "wearing off" when the underlying issue is cumulative sleep debt.

Nervous System Sensitivity and the Women Who Are Missed
A subset of women, often those with a history of anxiety, PMDD, migraines, or sensory sensitivity, have a more reactive response to hormonal fluctuation. For these women, even small changes in estrogen or progesterone can produce outsized symptoms, mood shifts, physical anxiety, heart palpitations, or a sense of being physiologically off balance.
This is not weakness. It is a real neurobiological difference in how fluctuations at the receptor level translate into how a woman feels day to day. For this group, the goal of HRT is often to achieve the steadiest possible hormonal levels, with the least fluctuation.
For women in this group, delivery method tends to matter even more. Patches and gels generally produce steadier levels than oral pills, and timing of application affects peak and trough levels. Untreated estrogen fluctuation can drive anxiety, and HRT that produces fluctuating levels can also contribute to it. For more sensitive women, observing how hormones and symptoms move together over time can be especially valuable for understanding what is happening, and for any conversations with your provider about adjusting an approach.
What "Optimization" Actually Requires
A single hormone test, drawn at one point in time, is rarely as useful as it sounds. This is part of why a generalized hormone panel is not typically part of routine perimenopause care. One value tells you what one moment looked like. It cannot show whether your estrogen has been steady or variable, how progesterone levels track with your sleep and mood, or whether the days you have felt better line up with particular hormonal patterns.
Daily hormone tracking adds context that a single test does not. Seeing your estrogen and progesterone levels day by day, alongside symptoms you log, makes it possible to observe patterns over time. Bad days may cluster around particular shifts. Good stretches may line up with steadier levels. Over weeks, the trend lines tell a story that a single value cannot.
This kind of visibility supports two things. The first is your own understanding of what your body is doing. Many women describe a relief that comes simply from seeing patterns they had been experiencing but could not name. The second is having something objective to consider as you navigate the midlife transition, whether that means understanding your own cycle, weighing a conversation about hormone therapy, or noticing how your body is responding to a medication change.
Whether you are on hormone therapy or not, the pattern of your hormones before, during, and after a change tells you more about how your body is actually responding than any single result can.
Start tracking your HRT response with Oova →
Frequently Asked Questions
Why do I feel worse after starting HRT?
The most common reasons are progesterone intolerance, a faster-than-comfortable estrogen titration, differences in how a particular delivery method is absorbed, or a dose that does not yet match your individual baseline. Feeling worse in the early weeks does not mean HRT is wrong for you. It may mean the approach needs to be revisited with your provider. Observing symptoms alongside hormone patterns can be useful for understanding which variable is in play.
Can progesterone cause anxiety on HRT?
Yes, for some women. Micronized progesterone is converted to allopregnanolone, a neurosteroid with GABA-modulating effects that is calming for most women but can produce low mood, anxiety, or brain fog in a subset. If anxiety worsens during the progesterone phase of a cyclical regimen, or after starting continuous progesterone, it is worth a conversation with your provider about alternative progestogen options.
Why did HRT work at first and then stop?
Perimenopause is not a static decline. Your ovaries continue to fluctuate even while you are on HRT, and an approach that fit your hormonal pattern three months ago may not fit it now. Tracking how your hormones and symptoms move over time can help make these shifts visible.
Does delivery method affect how HRT feels?
Yes, often significantly. Oral estrogen undergoes first-pass liver metabolism, producing different systemic effects than transdermal delivery. Patches, gels, and creams bypass liver metabolism, producing more stable blood levels. For women who are anxious or hormonally sensitive, transdermal delivery is often preferred. Even within transdermal options, absorption can vary between women and application sites.
How do I know if my HRT dose is right?
A single blood test gives a snapshot, not a pattern. Signs that an approach may need revisiting include persistent hot flashes or night sweats, ongoing sleep disruption, mood instability, or new anxiety or breast tenderness. Daily tracking, watching how your levels and symptoms move together, can give you more context for ongoing conversations with your provider.
About the author

Sources
- Baber RJ, Panay N, Fenton A. "2016 IMS Recommendations on women's midlife health and menopause hormone therapy." Climacteric. 2016;19(2):109–150.
- Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. "Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis." BMJ. 2008;336(7655):1227–1231.
- Prior JC. "Progesterone for symptomatic perimenopause treatment: Progesterone politics, physiology and potential for perimenopause." Facts Views Vis Obgyn. 2011;3(2):109–120.
- Stuenkel CA, Davis SR, Gompel A, et al. "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism. 2015;100(11):3975–4011.
- Backstrom T, Haage D, Lofgren M, et al. "Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some patients." Neuroscience. 2011;191:46–54.
- Scarabin PY, Oger E, Plu-Bureau G. "Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk." Lancet. 2003;362(9382):428–432.
- Gordon JL, Rubinow DR, Eisenlohr-Moul TA, et al. "Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition." JAMA Psychiatry. 2018;75(2):149–157.
About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.


